Letters
Volume 30—2024
Volume 30, Number 11—November 2024
Estimating Underdetection of Foodborne Disease Outbreaks
EID | Hedberg CW, Firestone MJ, Kim TN, Edmundson AR, Bender JB. Estimating Underdetection of Foodborne Disease Outbreaks. Emerg Infect Dis. 2024;30(11):2451. https://doi.org/10.3201/eid3011.240198 |
---|---|
AMA | Hedberg CW, Firestone MJ, Kim TN, et al. Estimating Underdetection of Foodborne Disease Outbreaks. Emerging Infectious Diseases. 2024;30(11):2451. doi:10.3201/eid3011.240198. |
APA | Hedberg, C. W., Firestone, M. J., Kim, T. N., Edmundson, A. R., & Bender, J. B. (2024). Estimating Underdetection of Foodborne Disease Outbreaks. Emerging Infectious Diseases, 30(11), 2451. https://doi.org/10.3201/eid3011.240198. |
Estimating Underdetection of Foodborne Disease Outbreaks (Response)
EID | Ford L, Self JL, Wong KK, Hoekstra RM, Tauxe RV, Rose E, et al. Estimating Underdetection of Foodborne Disease Outbreaks (Response). Emerg Infect Dis. 2024;30(11):2452. https://doi.org/10.3201/eid3011.241351 |
---|---|
AMA | Ford L, Self JL, Wong KK, et al. Estimating Underdetection of Foodborne Disease Outbreaks (Response). Emerging Infectious Diseases. 2024;30(11):2452. doi:10.3201/eid3011.241351. |
APA | Ford, L., Self, J. L., Wong, K. K., Hoekstra, R. M., Tauxe, R. V., Rose, E....Bruce, B. B. (2024). Estimating Underdetection of Foodborne Disease Outbreaks (Response). Emerging Infectious Diseases, 30(11), 2452. https://doi.org/10.3201/eid3011.241351. |
Volume 30, Number 8—August 2024
Transmission and Surveillance of Rat Hepatitis E Virus in Swine
EID | Bezerra M, Oliveira da Paz M, de Oliveira-Filho E, de Souza Reis C. Transmission and Surveillance of Rat Hepatitis E Virus in Swine. Emerg Infect Dis. 2024;30(8):1739. https://doi.org/10.3201/eid3008.240484 |
---|---|
AMA | Bezerra M, Oliveira da Paz M, de Oliveira-Filho E, et al. Transmission and Surveillance of Rat Hepatitis E Virus in Swine. Emerging Infectious Diseases. 2024;30(8):1739. doi:10.3201/eid3008.240484. |
APA | Bezerra, M., Oliveira da Paz, M., de Oliveira-Filho, E., & de Souza Reis, C. (2024). Transmission and Surveillance of Rat Hepatitis E Virus in Swine. Emerging Infectious Diseases, 30(8), 1739. https://doi.org/10.3201/eid3008.240484. |
Volume 30, Number 6—June 2024
Nontuberculous Mycobacteria and Laboratory Surveillance, Virginia, USA
EID | See I, Jackson KA, Byram R, Toney N, Grigg C, Magill SS. Nontuberculous Mycobacteria and Laboratory Surveillance, Virginia, USA. Emerg Infect Dis. 2024;30(6):1302. https://doi.org/10.3201/eid3006.240431 |
---|---|
AMA | See I, Jackson KA, Byram R, et al. Nontuberculous Mycobacteria and Laboratory Surveillance, Virginia, USA. Emerging Infectious Diseases. 2024;30(6):1302. doi:10.3201/eid3006.240431. |
APA | See, I., Jackson, K. A., Byram, R., Toney, N., Grigg, C., & Magill, S. S. (2024). Nontuberculous Mycobacteria and Laboratory Surveillance, Virginia, USA. Emerging Infectious Diseases, 30(6), 1302. https://doi.org/10.3201/eid3006.240431. |
Volume 30, Number 2—February 2024
No Evidence for Clade I Monkeypox Virus Circulation, Belgium
EID | Liesenborghs L, Coppens J, Van Dijck C, Brosius I, De Baetselier I, Vercauteren K, et al. No Evidence for Clade I Monkeypox Virus Circulation, Belgium. Emerg Infect Dis. 2024;30(2):402. https://doi.org/10.3201/eid3002.231746 |
---|---|
AMA | Liesenborghs L, Coppens J, Van Dijck C, et al. No Evidence for Clade I Monkeypox Virus Circulation, Belgium. Emerging Infectious Diseases. 2024;30(2):402. doi:10.3201/eid3002.231746. |
APA | Liesenborghs, L., Coppens, J., Van Dijck, C., Brosius, I., De Baetselier, I., Vercauteren, K....Van Esbroeck, M. (2024). No Evidence for Clade I Monkeypox Virus Circulation, Belgium. Emerging Infectious Diseases, 30(2), 402. https://doi.org/10.3201/eid3002.231746. |
Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan
EID | Iwata K. Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan. Emerg Infect Dis. 2024;30(2):403. https://doi.org/10.3201/eid3002.230827 |
---|---|
AMA | Iwata K. Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan. Emerging Infectious Diseases. 2024;30(2):403. doi:10.3201/eid3002.230827. |
APA | Iwata, K. (2024). Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan. Emerging Infectious Diseases, 30(2), 403. https://doi.org/10.3201/eid3002.230827. |
Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan (Response)
EID | Aita T, Sando E, Katoh S, Hamaguchi S, Fujita H, Kurita N. Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan (Response). Emerg Infect Dis. 2024;30(2):403-404. https://doi.org/10.3201/eid3002.231465 |
---|---|
AMA | Aita T, Sando E, Katoh S, et al. Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan (Response). Emerging Infectious Diseases. 2024;30(2):403-404. doi:10.3201/eid3002.231465. |
APA | Aita, T., Sando, E., Katoh, S., Hamaguchi, S., Fujita, H., & Kurita, N. (2024). Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan (Response). Emerging Infectious Diseases, 30(2), 403-404. https://doi.org/10.3201/eid3002.231465. |
Volume 30, Number 1—January 2024
Use of Zoo Mice in Study of Lymphocytic Choriomeningitis Mammarenavirus, Germany
EID | de Bellocq J, Baird S, Fornůsková A. Use of Zoo Mice in Study of Lymphocytic Choriomeningitis Mammarenavirus, Germany. Emerg Infect Dis. 2024;30(1):205. https://doi.org/10.3201/eid3001.230334 |
---|---|
AMA | de Bellocq J, Baird S, Fornůsková A. Use of Zoo Mice in Study of Lymphocytic Choriomeningitis Mammarenavirus, Germany. Emerging Infectious Diseases. 2024;30(1):205. doi:10.3201/eid3001.230334. |
APA | de Bellocq, J., Baird, S., & Fornůsková, A. (2024). Use of Zoo Mice in Study of Lymphocytic Choriomeningitis Mammarenavirus, Germany. Emerging Infectious Diseases, 30(1), 205. https://doi.org/10.3201/eid3001.230334. |
Use of Zoo Mice in Study of Lymphocytic Choriomeningitis Mammarenavirus, Germany (Response)
EID | Mehl C, Wylezich C, Geiger C, Schauerte N, Mätz-Rensing K, Nesseler A, et al. Use of Zoo Mice in Study of Lymphocytic Choriomeningitis Mammarenavirus, Germany (Response). Emerg Infect Dis. 2024;30(1):205-206. https://doi.org/10.3201/eid3001.231521 |
---|---|
AMA | Mehl C, Wylezich C, Geiger C, et al. Use of Zoo Mice in Study of Lymphocytic Choriomeningitis Mammarenavirus, Germany (Response). Emerging Infectious Diseases. 2024;30(1):205-206. doi:10.3201/eid3001.231521. |
APA | Mehl, C., Wylezich, C., Geiger, C., Schauerte, N., Mätz-Rensing, K., Nesseler, A....Ulrich, R. G. (2024). Use of Zoo Mice in Study of Lymphocytic Choriomeningitis Mammarenavirus, Germany (Response). Emerging Infectious Diseases, 30(1), 205-206. https://doi.org/10.3201/eid3001.231521. |
SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan
EID | Cheng H, Akhmetzhanov AR, Dushoff J. SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan. Emerg Infect Dis. 2024;30(1):206-207. https://doi.org/10.3201/eid3001.230208 |
---|---|
AMA | Cheng H, Akhmetzhanov AR, Dushoff J. SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan. Emerging Infectious Diseases. 2024;30(1):206-207. doi:10.3201/eid3001.230208. |
APA | Cheng, H., Akhmetzhanov, A. R., & Dushoff, J. (2024). SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan. Emerging Infectious Diseases, 30(1), 206-207. https://doi.org/10.3201/eid3001.230208. |
SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan (Response)
EID | Ogata T, Tanaka H. SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan (Response). Emerg Infect Dis. 2024;30(1):207. https://doi.org/10.3201/eid3001.231487 |
---|---|
AMA | Ogata T, Tanaka H. SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan (Response). Emerging Infectious Diseases. 2024;30(1):207. doi:10.3201/eid3001.231487. |
APA | Ogata, T., & Tanaka, H. (2024). SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan (Response). Emerging Infectious Diseases, 30(1), 207. https://doi.org/10.3201/eid3001.231487. |
Page created: November 07, 2023
Page updated: October 23, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.